{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:32:12Z","timestamp":1791304332748,"version":"4.3.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10072-019-03746-1","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T07:51:59Z","timestamp":1550476319000},"page":"1111-1124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Italian recommendations for the diagnosis and treatment of myasthenia gravis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0282-8787","authenticated-orcid":false,"given":"Amelia","family":"Evoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"DiMuzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Habetswallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Iani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Inghilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"key":"3746_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/ane.12233","volume":"198","author":"JB Andersen","year":"2014","unstructured":"Andersen JB, Heldal AT, Engeland A, Gihlus NE (2014) Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurol Scand Suppl 198:26\u201331","journal-title":"Acta Neurol Scand Suppl"},{"key":"3746_CR2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gihlus","year":"2015","unstructured":"Gihlus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023\u20131036","journal-title":"Lancet Neurol"},{"key":"3746_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Str\u00f6bel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875\u2013884","journal-title":"Autoimmun Rev"},{"key":"3746_CR4","doi-asserted-by":"publisher","first-page":"009167","DOI":"10.1101\/cshperspect.a009167","volume":"5","author":"SJ Burden","year":"2013","unstructured":"Burden SJ, Yumoto N, Zhang W (2013) The role of MuSK in synapse formation and neuromuscular disease. Cold Spring Harb Perspect Biol 5:009167","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3746_CR5","doi-asserted-by":"publisher","first-page":"20783","DOI":"10.1073\/pnas.1313944110","volume":"110","author":"MG Huijbers","year":"2013","unstructured":"Huijbers MG, Zhang W, Klooster R, Niks EH, Friese MB, Straasheijm KR, Thijssen PE, Vrolijk H, Plomp JJ, Vogels P, Losen M, van der Maarel SM, Burden SJ, Verschuuren JJ (2013) MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc Natl Acad Sci U S A 110:20783\u201320788","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3746_CR6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","volume":"12","author":"A Evoli","year":"2013","unstructured":"Evoli A, Padua L (2013) Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase. Autoimmun Rev 12:931\u2013935","journal-title":"Autoimmun Rev"},{"key":"3746_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/mus.20030","volume":"29","author":"JC Keesey","year":"2004","unstructured":"Keesey JC (2004) Clinical evaluation and management of myasthenia gravis. Muscle Nerve 29:484\u2013505","journal-title":"Muscle Nerve"},{"key":"3746_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/1941875210382918","volume":"1","author":"LC Wendell","year":"2011","unstructured":"Wendell LC, Levine JM (2011) Myasthenic crisis. Neurohospitalist 1:16\u201322","journal-title":"Neurohospitalist"},{"key":"3746_CR9","first-page":"1324","volume":"21","author":"AA Rabinstein","year":"2015","unstructured":"Rabinstein AA (2015) Acute neuromuscular respiratory failure. Continuum (Minneap Minn) 21:1324\u20131345","journal-title":"Continuum (Minneap Minn)"},{"key":"3746_CR10","unstructured":"Mehrizi M, Fontem RF, Gearhart TR, Pascuzzi RM (2012) Medications and myasthenia gravis (a reference for health care professionals). Myasthenia Gravis Foundation of America. \n                    http:\/\/www.myasthenia.org\/portals\/0\/draft_medications_and_myasthenia_gravis_for_MGFA_website\n                    \n                  . Published Summer 2015"},{"key":"3746_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejca.2017.05.041","volume":"82","author":"D Makarious","year":"2017","unstructured":"Makarious D, Horwood K, Coward JIG (2017) Myasthenia gravis: an emerging toxicity of immune checkpoint inhibitors. Eur J Cancer 82:128\u2013136","journal-title":"Eur J Cancer"},{"key":"3746_CR12","first-page":"57","volume":"8","author":"SF Schaller","year":"2013","unstructured":"Schaller SF, Fink H (2013) Sugammadex as a reversal agent for neuromuscular block: an evidence-based review. Core Evid 8:57\u201367","journal-title":"Core Evid"},{"key":"3746_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","volume":"52","author":"P Zisimopoulou","year":"2014","unstructured":"Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, DeBaets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Tzartos SJ (2014) A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. J Autoimmun 52:139\u2013145","journal-title":"J Autoimmun"},{"key":"3746_CR14","first-page":"497","volume":"38","author":"KE Osserman","year":"1971","unstructured":"Osserman KE, Genkins G (1971) Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 38:497\u2013537","journal-title":"Mt Sinai J Med"},{"key":"3746_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"5","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory Board of the Myasthenia Gravis Foundation of America. Neurology 5:16\u201323","journal-title":"Neurology"},{"key":"3746_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1749-6632.2012.06812.x","volume":"1274","author":"TM Burns","year":"2012","unstructured":"Burns TM (2012) The MG composite: an outcome measure for MG for use in clinical trials and everyday practice. Ann N Y Acad Sci 1274:99\u2013106","journal-title":"Ann N Y Acad Sci"},{"key":"3746_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1196\/annals.1254.057","volume":"998","author":"DB Sanders","year":"2003","unstructured":"Sanders DB, Tucker-Lipscomb B, Massey JM (2003) A simple manual muscle test for myasthenia gravis. Validation ad comparison with the QMG score. Ann N Y Acad Sci 998:440\u2013444","journal-title":"Ann N Y Acad Sci"},{"key":"3746_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/mus.24911","volume":"53","author":"C Antozzi","year":"2016","unstructured":"Antozzi C, Brenna G, Baggi F, Camera G, Maggi L, Rezzani C, Montomoli C, Mantegazza R (2016) Validation of the Besta Neurological Institute rating scale for myasthenia gravis. Muscle Nerve 53:32\u201337","journal-title":"Muscle Nerve"},{"key":"3746_CR19","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ (1999) Myasthenia gravis activities of daily living profile. Neurology 52:1487\u20131489","journal-title":"Neurology"},{"key":"3746_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/mus.10035","volume":"25","author":"L Padua","year":"2002","unstructured":"Padua L, Evoli A, Aprile I, Caliandro P, D'Amico P, Rabini A, Tonali P (2002) Quality of life in patients with myasthenia gravis. Muscle Nerve 25:466\u2013467","journal-title":"Muscle Nerve"},{"key":"3746_CR21","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mus.25545","volume":"56","author":"A Raggi","year":"2017","unstructured":"Raggi A, Leonardi M, Ayadi R, Antozzi C, Maggi L, Baggi F, Mantegazza R (2017) Validation of the Italian version of the 15-item myasthenia gravis quality-of-life questionnaire. Muscle Nerve 56:716\u2013720","journal-title":"Muscle Nerve"},{"key":"3746_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pmr.2012.08.013","volume":"24","author":"JF Howard Jr","year":"2013","unstructured":"Howard JF Jr (2013) Electrodiagnosis of disorders of neuromuscular transmission. Phys Med Rehabil Clin N Am 24:169\u2013192","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"3746_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/mus.880070211","volume":"7","author":"F Shumm","year":"1984","unstructured":"Shumm F, Stohr M (1984) Accessory nerve stimulation in the assessment of myasthenia gravis. Muscle Nerve 7:147\u2013151","journal-title":"Muscle Nerve"},{"key":"3746_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mus.20498","volume":"33","author":"SJ Oh","year":"2006","unstructured":"Oh SJ, Hatanaka Y, Hemmi S, Young AM, Scheufele ML, Nations SP, Lu L, Claussen GC, Wolfe GI (2006) Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis. Muscle Nerve 33:500\u2013504","journal-title":"Muscle Nerve"},{"key":"3746_CR25","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1069::AID-MUS1>3.0.CO;2-Y","volume":"19","author":"DB Sanders","year":"1996","unstructured":"Sanders DB, St\u00e5lberg EV (1996) AAEM Minimonograph #25: single-fiber electromyography. Muscle Nerve 19:1069\u20131083","journal-title":"Muscle Nerve"},{"key":"3746_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","volume":"16","author":"M Benatar","year":"2006","unstructured":"Benatar M (2006) A systematic revue of diagnostic studies in myasthenia gravis. Neuromuscul Disord 16:459\u2013467","journal-title":"Neuromuscul Disord"},{"key":"3746_CR27","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/mus.10141","volume":"11","author":"DB Sanders","year":"2002","unstructured":"Sanders DB (2002) The clinical impact of single-fiber electromyography. Muscle Nerve 11:S15\u2013S20","journal-title":"Muscle Nerve"},{"key":"3746_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/mus.880130302","volume":"13","author":"SJ Oh","year":"1990","unstructured":"Oh SJ, Cho HK (1990) Edrophonium responsiveness not necessarily diagnostic of myasthenia gravis. Muscle Nerve 13:187\u2013191","journal-title":"Muscle Nerve"},{"key":"3746_CR29","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1212\/WNL.39.6.865","volume":"39","author":"LY Dirr","year":"1989","unstructured":"Dirr LY, Donofrio PD, Patton JF, Troost BT (1989) A false-positive edrophonium test in a patient with a brainstem glioma. Neurology 39:865\u2013867","journal-title":"Neurology"},{"issue":"Suppl 2","key":"3746_CR30","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.1007\/s10072-017-3026-2","volume":"38","author":"F Andreetta","year":"2017","unstructured":"Andreetta F, Rinaldi E, Bartoccioni E et al (2017) Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies. Neurol Sci 38(Suppl 2):S253\u2013S257","journal-title":"Neurol Sci"},{"key":"3746_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/CND.0b013e31824db163","volume":"14","author":"R Mehanna","year":"2012","unstructured":"Mehanna R, Patton EL Jr, Phan CL et al (2012) Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies. Case report and review of the literature. J Clin Neuromuscul Dis 14:82\u201385","journal-title":"J Clin Neuromuscul Dis"},{"key":"3746_CR32","doi-asserted-by":"publisher","first-page":"7270","DOI":"10.1158\/1078-0432.CCR-04-0735","volume":"10","author":"S Vernino","year":"2004","unstructured":"Vernino S, Lennon VA (2004) Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 10:7270\u20137275","journal-title":"Clin Cancer Res"},{"key":"3746_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1586\/eci.12.34","volume":"8","author":"MN Meriggioli","year":"2012","unstructured":"Meriggioli MN, Sanders DB (2012) Muscle autoantibodies in myasthenia gravis: beyond diagnosis? Expert Rev Clin Immunol 8:427\u2013438","journal-title":"Expert Rev Clin Immunol"},{"key":"3746_CR34","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jamaneurol.2015.0203","volume":"72","author":"PM Rodr\u00edguez Cruz","year":"2015","unstructured":"Rodr\u00edguez Cruz PM, Al-Hajjar M, Huda S et al (2015) Clinical features and diagnostic usefulness of antibodies to clustered acetylcholine receptors in the diagnosis of seronegative myasthenia gravis. JAMA Neurol 72:642\u2013649","journal-title":"JAMA Neurol"},{"key":"3746_CR35","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1212\/NXI.0000000000000357","volume":"4","author":"S Huda","year":"2017","unstructured":"Huda S, Waters P, Woodhall M, Leite MI, Jacobson L, de Rosa A, Maestri M, Ricciardi R, Heckmann JM, Maniaol A, Evoli A, Cossins J, Hilton-Jones D, Vincent A (2017) IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG. Neurol Neuroimmunol Neuroinflamm 4:e357","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3746_CR36","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/mus.23857","volume":"48","author":"MO Fakiri","year":"2013","unstructured":"Fakiri MO, Tavy DL, Hama-Amin AD, Wirtz PW (2013) Accuracy of the ice test in the diagnosis of myasthenia gravis in patients with ptosis. Muscle Nerve 48:902\u2013904","journal-title":"Muscle Nerve"},{"key":"3746_CR37","doi-asserted-by":"publisher","unstructured":"Maggi L, Bernasconi P, D'Amico A et al (2018) Italian recommendations for diagnosis and management of congenital myasthenic syndromes. Neurol Sci. \n                    https:\/\/doi.org\/10.1007\/s10072-018-3682-x","DOI":"10.1007\/s10072-018-3682-x"},{"key":"3746_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/acn3.26","volume":"1","author":"JS Tzartos","year":"2014","unstructured":"Tzartos JS, Zisimopoulou P, Rentzos M, Karandreas N, Zouvelou V, Evangelakou P, Tsonis A, Thomaidis T, Lauria G, Andreetta F, Mantegazza R, Tzartos SJ (2014) LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients. Ann Clin Transl Neurol 1:80\u201387","journal-title":"Ann Clin Transl Neurol"},{"key":"3746_CR39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/jnnp.2003.023630","volume":"75","author":"YL Lo","year":"2004","unstructured":"Lo YL, Chan LL, Pan A et al (2004) Acute ophthalmoparesis in the anti-GQ1b antibody syndrome: electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi. J Neurol Neurosurg Psychiatry 75:436\u2013440","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3746_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/NDT.S8915","volume":"7","author":"R Mantegazza","year":"2011","unstructured":"Mantegazza R, Bonanno S, Camera G et al (2011) Current and emerging therapies for the treatment of myasthenia gravis. Neuropsychiatr Dis Treat 7:151\u2013160","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3746_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1212\/WNL.34.2.170","volume":"34","author":"A Sghirlanzoni","year":"1984","unstructured":"Sghirlanzoni A, Peluchetti D, Mantegazza R, Fiacchino F, Cornelio F (1984) Myasthenia gravis: prolonged treatment with steroids. Neurology 34:170\u2013174","journal-title":"Neurology"},{"key":"3746_CR42","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/08916930903518107","volume":"43","author":"DB Sanders","year":"2010","unstructured":"Sanders DB, Evoli A (2010) Immunosuppressive therapies in myasthenia gravis. Autoimmunity 43:428\u2013435","journal-title":"Autoimmunity"},{"key":"3746_CR43","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/ene.12359","volume":"21","author":"E Kerty","year":"2014","unstructured":"Kerty E, Elsais A, Argov Z, Evoli A, Gilhus NE (2014) EFNS\/ENS guidelines for the treatment of ocular myasthenia. Eur J Neurol 21:687\u2013693","journal-title":"Eur J Neurol"},{"key":"3746_CR44","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","volume":"50","author":"J Palace","year":"1998","unstructured":"Palace J, Newsom-Davis J, Lecky B (1998) A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Neurology 50:1778\u20131783","journal-title":"Neurology"},{"key":"3746_CR45","volume-title":"Source medical genetics summaries [Internet]","author":"L Dean","year":"2012","unstructured":"Dean L (2012) Azathioprine therapy and TPMT genotype. In: Pratt V, McLeod H, Dean L, Malheiro A, Rubinstein W (eds) Source medical genetics summaries [Internet]. National Center for Biotechnology Information (US), Bethesda [updated 2016 May 3]"},{"key":"3746_CR46","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1196\/annals.1405.031","volume":"1132","author":"DB Sanders","year":"2008","unstructured":"Sanders DB, Siddiqi ZA (2008) Lessons from two trials of mycophenolate mofetil in myasthenia gravis. Ann N Y Acad Sci 1132:249\u2013255","journal-title":"Ann N Y Acad Sci"},{"key":"3746_CR47","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/mus.21640","volume":"41","author":"MK Hehir","year":"2010","unstructured":"Hehir MK, Burns TM, Alpers J, Conaway MR, Sawa M, Sanders DB (2010) Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: outcomes in 102 patients. Muscle Nerve 41:593\u2013598","journal-title":"Muscle Nerve"},{"key":"3746_CR48","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jns.2016.08.057","volume":"369","author":"L Gotterer","year":"2016","unstructured":"Gotterer L, Li Y (2016) Maintenance immunosuppression in myasthenia gravis. J Neurol Sci 369:294\u2013302","journal-title":"J Neurol Sci"},{"key":"3746_CR49","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1749-6632.1993.tb22937.x","volume":"681","author":"RS Tindall","year":"1993","unstructured":"Tindall RS, Phillips JT, Rollins JA et al (1993) A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann N Y Acad Sci 681:539\u2013551","journal-title":"Ann N Y Acad Sci"},{"key":"3746_CR50","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1756285615571873","volume":"8","author":"JL Cruz","year":"2015","unstructured":"Cruz JL, Wolff ML, Vanderman AJ, Brown JN (2015) The emerging role of tacrolimus in myasthenia gravis. Ther Adv Neurol Disord 8:92\u2013103","journal-title":"Ther Adv Neurol Disord"},{"key":"3746_CR51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000085833","volume":"53","author":"Y Nagane","year":"2005","unstructured":"Nagane Y, Utsugisawa K, Obara D, Kondoh R, Terayama Y (2005) Efficacy of low-dose FK506 in the treatment of myasthenia gravis-a randomized pilot study. Eur Neurol 53:146\u2013150","journal-title":"Eur Neurol"},{"key":"3746_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2377-11-97","volume":"11","author":"JM Heckmann","year":"2015","unstructured":"Heckmann JM, Rawoot A, Bateman K et al (2015) A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis. BMC Neurol 11:97","journal-title":"BMC Neurol"},{"key":"3746_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1212\/WNL.0000000000002795","volume":"87","author":"M Pasnoor","year":"2016","unstructured":"Pasnoor M, He J, Herbelin L, Burns TM, Nations S, Bril V, Wang AK, Elsheikh BH, Kissel JT, Saperstein D, Shaibani JA, Jackson C, Swenson A, Howard JF Jr, Goyal N, David W, Wicklund M, Pulley M, Becker M, Mozaffar T, Benatar M, Pazcuzzi R, Simpson E, Rosenfeld J, Dimachkie MM, Statland JM, Barohn RJ, The Methotrexate in MG Investigators of the Muscle Study Group (2016) A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis. Neurology 87:57\u201364","journal-title":"Neurology"},{"key":"3746_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, Kuntz N, Massey JM, Melms A, Murai H, Nicolle M, Palace J, Richman DP, Verschuuren J, Narayanaswami P (2016) International consensus guidance for management of myasthenia gravis: executive summary. Neurology 87:419\u2013425","journal-title":"Neurology"},{"key":"3746_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mus.10133","volume":"26","author":"LG Feo de","year":"2002","unstructured":"de Feo LG, Schottlender J, Martelli NA, Molfino NA (2002) Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis. Muscle Nerve 26:31\u201336","journal-title":"Muscle Nerve"},{"key":"3746_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.nmd.2016.12.004","volume":"27","author":"V Afanasiev","year":"2017","unstructured":"Afanasiev V, Demeret S, Bolgert F, Eymard B, Lafor\u00eat P, Benveniste O (2017) Resistant myasthenia gravis and rituximab: a monocentric retrospective study of 28 patients. Neuromuscul Disord 27:251\u2013258","journal-title":"Neuromuscul Disord"},{"key":"3746_CR57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/mus.25597","volume":"56","author":"R Tandan","year":"2017","unstructured":"Tandan R, Hehir MK 2nd, Waheed W, Howard DB (2017) Rituximab treatment of myasthenia gravis: a systematic review. Muscle Nerve 56:185\u2013196","journal-title":"Muscle Nerve"},{"key":"3746_CR58","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1212\/CPJ.0000000000000202","volume":"6","author":"KM Kanth","year":"2016","unstructured":"Kanth KM, Solorzano GE, Goldman MD (2016) PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents. Neurol Clin Pract 6:e17\u2013e19","journal-title":"Neurol Clin Pract"},{"issue":"16","key":"3746_CR59","doi-asserted-by":"publisher","first-page":"e1425","DOI":"10.1212\/WNL.0000000000005323","volume":"90","author":"K Hewett","year":"2018","unstructured":"Hewett K, Sanders DB, Grove RA, Broderick CL, Rudo TJ, Bassiri A, Zvartau-Hind M, Bril V, On behalf of the BEL115123 Study Group (2018) Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis. Neurology 90(16):e1425\u2013e1434","journal-title":"Neurology"},{"key":"3746_CR60","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","volume":"16","author":"JF Howard Jr","year":"2017","unstructured":"Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R, Mazia CG, Wilken M, Ortea C, Saba J, Rugiero M, Bettini M, Vidal G, Garcia AD, Lamont P, Leong WK, Boterhoven H, Fyfe B, Roberts L, Jasinarachchi M, Willlems N, Wanschitz J, L\u00f6scher W, de Bleecker J, van den Abeele G, de Koning K, de Mey K, Mercelis R, Wagemaekers L, Mahieu D, van Damme P, Smetcoren C, Stevens O, Verjans S, D'Hondt A, Tilkin P, Alves de Siqueira Carvalho A, Hasan R, Dias Brockhausen I, Feder D, Ambrosio D, Melo AP, Rocha R, Rosa B, Veiga T, Augusto da Silva L, Gon\u00e7alves Geraldo J, da Penha Morita Ananias M, Nogueira Coelho E, Paiva G, Pozo M, Prando N, Dada Martineli Torres D, Fernanda Butinhao C, Coelho E, Renata Cubas Volpe L, Duran G, Gomes da Silva TC, Otavio Maia Gon\u00e7alves L, Pazetto LE, Souza Duca L, Suriane Fialho TA, Gheller Friedrich MA, Guerreiro A, Mohr H, Pereira Martins M, da Cruz Pacheco D, Macagnan AP, de Cassia Santos A, Bulle Oliveira AS, Amaral de Andrade AC, Annes M, Cavalcante Lino V, Pinto W, Miranda C, Carrara F, Souza I, Genge A, Massie R, Campbell N, Bril V, Katzberg H, Soltani M, Ng E, Siddiqi Z, Phan C, Blackmore D, Vohanka S, Bednarik J, Chmelikova M, Cierny M, Toncrova S, Junkerova J, Kurkova B, Reguliova K, Zapletalova O, Pitha J, Novakova I, Tyblova M, Wolfova M, Jurajdova I, Andersen H, Harbo T, Vinge L, Mogensen A, H\u00f8jgaard J, Witting N, Autzen AM, Pedersen J, F\u00e4rkkil\u00e4 M, Atula S, Nyrhinen A, Er\u00e4linna JP, Laaksonen M, Oksaranta O, Eriksson J, Harrison T, Desnuelle C, Sacconi S, Soriani MH, Decressac S, Moutarde J, Lahaut P, Sol\u00e9 G, le Masson G, Wielanek-Bachelet AC, Gaboreau M, Moreau C, Wilson A, Vial C, Bouhour F, Gervais-Bernard H, Merle H, Hourquin C, Lacour A, Outteryck O, Vermersch P, Zephir H, Millois E, Deneve M, Deruelle F, Schoser B, Wenninger S, Stangel M, Alvermann S, Gingele S, Skripuletz T, Suehs KW, Trebst C, Fricke K, Papagiannopoulos S, Bostantzopoulou S, Vlaikidis N, Zampaki M, Papadopoulou N, Mitsikostas DD, Kasioti E, Mitropoulou E, Charalambous D, Rozsa C, Horvath M, Lovas G, Matolcsi J, Szabo G, Szabadosne B, Vecsei L, Dezsi L, Varga E, Konyane M, Gross B, Azrilin O, Greenbereg N, Bali Kuperman H, Antonini G, Garibaldi M, Morino S, Troili F, di Pasquale A, Filla A, Costabile T, Marano E, Sacca F, Marsil A, Puorro G, Maestri Tassoni M, de Rosa A, Bonanno S, Antozzi C, Maggi L, Campanella A, Angelini C, Cudia P, Pegoraro V, Pinzan E, Bevilacqua F, Orrico D, Bonifati DM, Evoli A, Alboini PE, D'Amato V, Iorio R, Inghilleri M, Fionda L, Frasca V, Giacomelli E, Gori M, Lopergolo D, Onesti E, Gabriele M, Patti F, Salvatore Caramma A, Messina S, Reggio E, Caserta C, Uzawa A, Kanai T, Mori M, Kaneko Y, Kanzaki A, Kobayashi E, Masaki K, Matsuse D, Matsushita T, Uehara T, Shimpo M, Jingu M, Kikutake K, Nakamura Y, Sano Y, Nagane Y, Kamegamori I, Fujii Y, Futono K, Tsuda T, Saito Y, Suzuki H, Morikawa M, Samukawa M, Kamakura S, Shiraishi H, Mitazaki T, Motomura M, Mukaino A, Yoshimura S, Asada S, Kobashikawa T, Koga M, Maeda Y, Takada K, Takada MT, Yamashita Y, Yoshida S, Suzuki Y, Akiyama T, Narikawa K, Tsukita K, Meguro F, Fukuda Y, Sato M, Matsuo H, Fukudome T, Gondo Y, Maeda Y, Nagaishi A, Nakane S, Okubo Y, Okumura M, Funaka S, Kawamura T, Makamori M, Takahashi M, Hasuike T, Higuchi E, Kobayashi H, Osakada K, Taichi N, Tsuda E, Hayashi T, Hisahara S, Imai T, Kawamata J, Murahara T, Saitoh M, Shimohama S, Suzuki S, Yamamoto D, Konno S, Imamura T, Inoue M, Murata M, Nakazora H, Nakayama R, Ikeda Y, Ogawa M, Shirane M, Kanda T, Kawai M, Koga M, Ogasawara J, Omoto M, Sano Y, Arima H, Fukui S, Shimose S, Shinozaki H, Watanabe M, Yoshikawa C, van der Kooi A, de Visser M, Gibson T, Maessen J, de Baets M, Faber C, Keijzers MJ, Miesen M, Kostera-Pruszczyk A, Kaminska A, Kim BJ, Lee CN, Koo YS, Seok HY, Kang HN, Ra HJ, Kim BJ, Cho EB, Lee HL, Min JH, Seok J, Koh DY, Kwon JY, Lee JE, Park SA, Hong YH, Lim JS, Kim MR, Kim SM, Kim YH, Lee HS, Shin HY, Hwang EB, Shin MJ, Sazonov D, Yarmoschuk A, Babenko L, Malkova N, Melnikova A, Korobko D, Kosykh E, Pokhabov D, Nesterova Y, Abramov V, Balyazin V, Casasnovas Pons C, Alberti Aguilo M, Homedes-Pedret C, Palacios NJ, Lazaro A, Diez Tejedor E, Fernandez-Fournier M, Lopez Ruiz P, Rodriguez de Rivera FJ, Salvado Figueras M, Gamez J, Salvado M, Cortes Vicente E, Diaz-Manera J, Querol Gutierrez L, Rojas Garcia R, Vidal N, Arribas-Ibar E, Piehl F, Hietala A, Bjarbo L, Lindberg C, Jons D, Andersson B, Sengun I, Ozcelik P, Tuga C, Ugur M, Boz C, Altiparmak D, Gazioglu S, Ozen Aydin C, Erdem-Ozdamar S, Bekircan-Kurt CE, Yilmaz E, Acar NP, Caliskan Y, Efendi H, Aydinlik S, Cavus H, Semiz C, Tun O, Terzi M, Dogan B, Onar MK, Sen S, Cavdar TK, Norwood F, Dimitriou A, Gollogly J, Mahdi-Rogers M, Seddigh A, Maier G, Sohail F, Sathasivam S, Arndt H, Davies D, Watling D, Rivner M, Hartmann JE, Quarles B, Smalley N, Amato A, Cochrane T, Salajegheh M, Roe K, Amato K, Toska S, Wolfe G, Silvestri N, Patrick K, Zakalik K, Katz J, Miller R, Engel M, Bravver E, Brooks B, Plevka S, Burdette M, Sanjak M, Kramer M, Nemeth J, Schommer C, Juel V, Guptill J, Hobson-Webb L, Beck K, Carnes D, Loor J, Anderson A, Lange D, Agopian E, Goldstein J, Manning E, Kaplan L, Holzberg S, Kassebaum N, Pascuzzi R, Bodkin C, Kincaid J, Snook R, Guinrich S, Micheels A, Chaudhry V, Corse A, Mosmiller B, Ho D, Srinivasan J, Vytopil M, Ventura N, Scala S, Carter C, Donahue C, Herbert C, Weiner E, McKinnon J, Haar L, McKinnon N, Alcon K, Daniels K, Sattar N, Jeffery D, McKenna K, Guidon A, David W, Dheel C, Levine-Weinberg M, Nigro C, Simpson E, Appel SH, Lai E, Lay L Jr, Pleitez M, Halton S, Faigle C, Thompson L, Sivak M, Shin S, Bratton J, Jacobs D, Brown G, Bandukwala I, Brown M, Kane J, Blount I, Freimer M, Hoyle JC, Agriesti J, Khoury J, Marburger T, Kaur H, Dimitrova D, Mellion M, Sachs G, Crabtree B, Keo R, Perez EK, Taber S, Gilchrist J, Andoin A, Darnell T, Goyal N, Sakamuri S, So YT, Welsh LW, Bhavaraju-Sanka R, Tobon Gonzalez A, Jones F, Saklad A, Nations S, Trivedi J, Hopkins S, Kazamel M, Alsharabati M, Lu L, Mumfrey-Thomas S, Woodall A, Richman D, Butters J, Lindsay M, Mozaffar T, Cash T, Goyal N, Roy G, Mathew V, Maqsood F, Minton B, Jones HJ, Rosenfeld J, Garcia R, Garcia S, Echevarria L, Pulley M, Aranke S, Berger AR, Shah J, Shabbir Y, Smith L, Varghese M, Gutmann L, Gutmann L, Swenson A, Olalde H, Hafer-Macko C, Kwan J, Zilliox L, Callison K, DiSanzo B, Naunton K, Bilsker M, Sharma K, Reyes E, Cooley A, Michon SC, Steele J, Karam CK, Chopra M, Bird S, Kaufman J, Gallatti N, Vu T, Katzin L, McClain T, Harvey B, Hart A, Huynh K, Beydoun S, Chilingaryan A, Droker B, Lin F, Shah A, Tran A, Akhter S, Malekniazi A, Tandan R, Hehir M, Waheed W, Lucy S, Weiss M, Distad J, Downing S, Strom S, Lisak R, Bernitsas E, Khan O, Kumar Sriwastava S, Tselis A, Jia K, Bertorini T, Arnold T, Henderson K, Pillai R, Liu Y, Wheeler L, Hewlett J, Vanderhook M, Dicapua D, Keung B, Kumar A, Patwa H, Robeson K, Nye J, Vu H (2017) Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol 16:976\u2013986","journal-title":"Lancet Neurol"},{"key":"3746_CR61","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ana.410410615","volume":"41","author":"P Gajdos","year":"1997","unstructured":"Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C, for the Myasthenia Gravis Clinical Study Group (1997) Clinical trial of plasma exchange and high-dose intravenous immunoglobulins in myasthenia gravis. Ann Neurol 41:789\u2013796","journal-title":"Ann Neurol"},{"key":"3746_CR62","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","volume":"76","author":"D Barth","year":"2011","unstructured":"Barth D, Nabavi Nouri M, Ng E, Nwe P, Bril V (2011) Comparison of IVIg and PLEX in patients with myasthenia gravis. Neurology 76:2017\u20132023","journal-title":"Neurology"},{"key":"3746_CR63","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/NRL.0000000000000026","volume":"19","author":"PS Dhawan","year":"2015","unstructured":"Dhawan PS, Goodman BP, Harper CM, Bosch PE, Hoffman-Snyder CR, Wellik KE, Wingerchuk DM, Demaerschalk BM (2015) IVIG versus PLEX in the treatment of worsening myasthenia gravis: what is the evidence? A critically appraised topic. Neurologist 19:145\u2013148","journal-title":"Neurologist"},{"key":"3746_CR64","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.atherosclerosissup.2012.10.027","volume":"14","author":"C Antozzi","year":"2013","unstructured":"Antozzi C (2013) Immunoadsorption in patients with autoimmune ion channel disorders of the peripheral nervous system. Atheroscler Suppl 14:219\u2013222","journal-title":"Atheroscler Suppl"},{"key":"3746_CR65","doi-asserted-by":"publisher","first-page":"e0159993","DOI":"10.1371\/journal.pone.0159993","volume":"11","author":"PR Bourque","year":"2016","unstructured":"Bourque PR, Pringle CE, Cameron W, Cowan J, Chardon JW (2016) Subcutaneous immunoglobulin therapy in the chronic management of myasthenia gravis: a retrospective cohort study. PLoS One 11:e0159993","journal-title":"PLoS One"},{"key":"3746_CR66","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, Str\u00f6bel P, Mazia C, Oger J, Cea JG, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BR, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Garcia Ramos GS, Verschuuren JJ, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Odenkirchen J, Sonett JR, Jaretzki A 3rd, Newsom-Davis J, Cutter GR, MGTX Study Group (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375:511\u2013522","journal-title":"N Engl J Med"},{"key":"3746_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0022-510X(03)00087-X","volume":"212","author":"R Mantegazza","year":"2003","unstructured":"Mantegazza R, Baggi F, Bernasconi P, Antozzi C, Confalonieri P, Novellino L, Spinelli L, Ferr\u00f2 MT, Beghi E, Cornelio F (2003) Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up. J Neurol Sci 212:31\u201336","journal-title":"J Neurol Sci"},{"key":"3746_CR68","first-page":"38","volume":"5","author":"R Ricciardi","year":"2016","unstructured":"Ricciardi R, Melfi F, Maestri M, de Rosa A, Petsa A, Lucchi M, Mussi A (2016) Endoscopic thymectomy: a neurologist's perspective. Ann Cardiothorac Surg 5:38\u201344","journal-title":"Ann Cardiothorac Surg"},{"key":"3746_CR69","first-page":"558","volume":"4","author":"F Rea","year":"2015","unstructured":"Rea F, Schiavon M, Marulli G (2015) Robotic thymectomy for myasthenia gravis. Ann Cardiothorac Surg 4:558\u2013560","journal-title":"Ann Cardiothorac Surg"},{"key":"3746_CR70","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","volume":"43","author":"G Bandoli","year":"2017","unstructured":"Bandoli G, Palmsten K, Forbess Smith CJ, Chambers CD (2017) A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin N Am 43:489\u2013502","journal-title":"Rheum Dis Clin N Am"},{"key":"3746_CR71","volume-title":"Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk","author":"GG Briggs","year":"2015","unstructured":"Briggs GG, Freeman RK, Yaffe SJ (2015) Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Wolters Kluwer\/Lippincott Williams & Wilkins Health, Philadelphia"},{"key":"3746_CR72","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1212\/NXI.0000000000000453","volume":"5","author":"G Das","year":"2018","unstructured":"Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R (2018) Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm 5:e453","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3746_CR73","volume":"2017","author":"AJ Lake","year":"2017","unstructured":"Lake AJ, AI Khabbaz A, Keeney R (2017) Severe preeclampsia in the setting of myasthenia gravis. Case Rep Obstet Gynecol 2017:9204930","journal-title":"Case Rep Obstet Gynecol"},{"key":"3746_CR74","doi-asserted-by":"publisher","first-page":"bcr2014208323","DOI":"10.1136\/bcr-2014-208323","volume":"2015","author":"J Ozcan","year":"2015","unstructured":"Ozcan J, Balson IF, Dennis AT (2015) New diagnosis myasthenia gravis and preeclampsia in late pregnancy. BMJ Case Rep 2015:bcr2014208323. \n                    https:\/\/doi.org\/10.1136\/bcr-2014-208323","journal-title":"BMJ Case Rep"},{"key":"3746_CR75","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1016\/j.vaccine.2014.09.003","volume":"32","author":"S Esposito","year":"2014","unstructured":"Esposito S, Bruno C, Berardinelli A, Filosto M, Mongini T, Morandi L, Musumeci O, Pegoraro E, Siciliano G, Tonin P, Marrosu G, Minetti C, Servida M, Fiorillo C, Conforti G, Scapolan S, Ansaldi F, Vianello A, Castaldi S, Principi N, Toscano A, Moggio M (2014) Vaccination recommendations for patients with neuromuscular disease. Vaccine 32:5893\u20135900","journal-title":"Vaccine"},{"key":"3746_CR76","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3988\/jcn.2017.13.4.325","volume":"14","author":"HY Seok","year":"2017","unstructured":"Seok HY, Shin HY, Kim JK et al (2017) The impacts of influenza infection and vaccination on exacerbation of myasthenia gravis. J Clin Neurol 14:325\u2013330","journal-title":"J Clin Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-03746-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03746-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-03746-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T11:26:45Z","timestamp":1582025205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-03746-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["3746"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-03746-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,18]]},"assertion":[{"value":"16 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Amelia Evoli served on an advisory board for Alexion and as jury member for research grant award for Grifols.Giovanni Antonini received conference honoraries from Kedrion, Sanofi-Genzyme and travel grants from Kedrion, Sanofi-Genzyme, Pfizer, Almylan.Carlo Antozzi has no conflicts of interest to disclose.Antonio Di Muzio has no conflicts of interest to disclose.Francesco Habetswallner has no conflicts of interest to disclose.Cesare Iani has no conflicts of interest to disclose.Maurizio Inghilleri has no conflicts of interest to disclose.Rocco Liguori served on advisory boards for Biogen, Sanofi-Genzyme, Argon Healthcare s.r.l., Editree Eventi s.r.l., received Lecture fees from Dynamicom Education, SIMG Service, Adnkronos Salute unipersonale s.r.l., DOC Congress s.r.l., First Class s.r.l., and is a consultant for Alfasigma and Amicus Therapeutics s.r.l.Renato Mantegazza has received funding for travel or meeting attendance from: Sanofi-Aventis, Teva, Biomarin, Alexion, Argenx, Novartis, Catalyst, Merck, and for advisory boards or SSC from: Biomarin, Alexion, Argenx.Roberto Massa received Travel grants from Sanofi-Genzyme, CSL-Behring, Pfizer, Almylan.Elena Pegoraro reports personal fees from PTC Therapeutics, Santhera, Roche and Sanofi-Genzyme.Roberta Ricciardi has no conflicts of interest to disclose.Carmelo Rodolico has no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}